Upcoming Studies

COVID-19

SITE: Brownsville, Texas | AGE: >18 | DURATION: 4 on site visits, 2 telehealth visits; total 45 days A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Orally Administered Dapansutrile Capsules for the Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome.

Colon Cancer Screening

SITE: Brownsville, Texas | AGE: 45 to 85 | DURATION: 90 days PREEMPT CRC: Prevention of Colorectal Cancer Through Multiomics Blood Testing: FRNM-004 multi-center validation study for a blood test screening for colorectal cancer.\

COVID-19

SITE: Brownsville, Texas | AGE: 18 to 49 (Part A) and 50 to 85 (Part B) | DURATION: 11 on site visits, 3 phone visits; total 1 year A Phase I/II, First in human, Observer Blinded, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVIF-19 SARS-CoV-2 Vaccine with CpG Adjuvant in …

COVID-19 Read More »

COVID-19

SITE: Brownsville, Texas | AGE: 18 to 49 (Part A) and 50 to 85 (Part B) | DURATION: 11 on site visits, 3 phone visits; total 1 year | REIMBURSEMENT: $2000 USD

COVID-19

SITE: Brownsville, Texas | AGE: >18 | DURATION: 4 on site visits, 2 telehealth visits; total 45 days | REIMBURSEMENT: $350 USD (Prepaid VISA cards)